Purpose
To accelerate the inclusion of the new polio VLP into the pentavalent (HepB, Hib, DTWcP) combination vaccine in support of polio VLPs as tools for the post-eradication era.
Grantee
Division
Global Health
Date
DECEMBER 2024
Region served
GLOBAL
Committed amount
$4,096,351
Grant topic
Vaccine Development
Duration (months)
35
Grantee location
Cambridge, MA, United States
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.